MaR1 has been shown in vivo to block NF-κB activation in colonic tissues in a murine colitis model [9], however MaR1 was found to have no inhibitory effect on NF-κB activation in human bronchial epithelial cells [8]. The gene discussed is NFKB1; the disease is colitis.